Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation (2011)
- Authors:
- USP affiliated authors: FANELLI, CAMILLA - FM ; FUJIHARA, CLARICE KAZUE - FM ; ZATZ, ROBERTO - FM
- Unidade: FM
- DOI: 10.1152/ajprenal.00042.2011
- Subjects: NEFROPATIAS (TERAPIA); ANGIOTENSINA II; INSUFICIÊNCIA RENAL CRÔNICA (TERAPIA;CONTROLE)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: American Journal of Physiology. Renal Physiology
- ISSN: 1931-857X
- Volume/Número/Paginação/Ano: v. 301, n. 3, p. F580-F587, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
FANELLI, C. et al. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation. American Journal of Physiology. Renal Physiology, v. 301, n. 3, p. F580-F587, 2011Tradução . . Disponível em: https://doi.org/10.1152/ajprenal.00042.2011. Acesso em: 15 maio 2024. -
APA
Fanelli, C., Fernandes, B. H. V., Machado, F. G., Okabe, C., Malheiros, D. M. A. C., Fujihara, C. K., & Zatz, R. (2011). Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation. American Journal of Physiology. Renal Physiology, 301( 3), F580-F587. doi:10.1152/ajprenal.00042.2011 -
NLM
Fanelli C, Fernandes BHV, Machado FG, Okabe C, Malheiros DMAC, Fujihara CK, Zatz R. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation [Internet]. American Journal of Physiology. Renal Physiology. 2011 ; 301( 3): F580-F587.[citado 2024 maio 15 ] Available from: https://doi.org/10.1152/ajprenal.00042.2011 -
Vancouver
Fanelli C, Fernandes BHV, Machado FG, Okabe C, Malheiros DMAC, Fujihara CK, Zatz R. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation [Internet]. American Journal of Physiology. Renal Physiology. 2011 ; 301( 3): F580-F587.[citado 2024 maio 15 ] Available from: https://doi.org/10.1152/ajprenal.00042.2011 - Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload
- Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD)
- Losartan (L) and Hydrochlorothiazide (H)Treatment (LH) arrests renal and cardiac injury in advanced chronic kidney disease by mechanisms not entireky dependent on blood pressure
- Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX)
- Associação terapêutica de losartan (L) e hidroclorotiazida (H) previne progressão da lesão renal em modelo de nefropatia crônica resultante da administração de (L) durante a lactação
- Mechanisms of progressive renal injury in adult rats treated with losartan during lactation
- NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy
- Combined Losartan (L) and Hydrocholorothyazide (H) treatment (LH) prevents progression of chronic kidney disease (CKD) resulting from L treatment during lactation (LLac)
- Regressão da nefropatia diabética experimental: Ausência de efeito dose resposta de um antagonista da angiotensina II
- Linking Oxidative Stress, the Renin-Angiotensin System, and Hypertension [Editorial]
Informações sobre o DOI: 10.1152/ajprenal.00042.2011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
